Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Franco Muggia, MD
Anne Murnick Cogan and David H. Cogan Professor of Oncology, Director of the Division of Medical Oncology at NYU Medical Center, and Associate Director for Clinical Research
Principal Investigator - Jonathan S Berek, MD, MMS
Professor and Chair, Department of Obstetrics and Gynecology Stanford University School of Medicine Stanford Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Decatur Memorial Hospital, Clinical Research Department/ Cancer Care Specialists of Illinois
Decatur, Illinois, United States
- University of Minnesota Medical Center
Minneapolis, Minnesota, United States
- Schwartz Gynecologic Onclology, Pllc
Brightwaters, New York, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Chattanooga Gyn Oncology
Chattanooga, Tennessee, United States
- the Methodist Hospital
Houston, Texas, United States
- Riverside Gynecology & Oncology
Newport News, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 31 Oct 2009
- Completion
- 31 May 2010
- Last update posted
- 12 Jun 2020
- Registered enrollment
- 0
- Registry id
- NCT00753740
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.